Literature DB >> 19641969

Risk factors associated with conversion from nonmalignant to malignant diagnosis after surgical excision of breast papillary lesions.

Tsung-Yen Cheng1, Chii-Ming Chen, Ming-Yuan Lee, Kwang-Jane Lin, Cheng-Fung Hung, Po-Sheng Yang, Ben-Long Yu, Chen-En Yang, Tzu-Jung Tsai, Chung-Wei Lin.   

Abstract

PURPOSE: Management of papillary lesions of the breast identified during preoperative tissue diagnosis remains controversial. This study was designed to analyze the clinical factors associated with under-diagnosis of malignancy in breast papillary lesions.
METHODS: Patients with a preoperative tissue diagnosis of benign or atypical papillary lesions, who received surgical excision between 1991 and 2005, were identified. Age of diagnosis, family history of breast cancer, presentation of nipple discharge, palpable mass, mammogram grading, size of lesion, and final pathological diagnosis were analyzed. Tissue sections were reviewed to confirm the diagnosis of malignancy and reasons of discrepancy.
RESULTS: A total of 205 women with 228 papillary lesions were studied. The median age was 42 (range, 12-83) years. Malignancies were diagnosed after surgery in 21 cases (9.2%). Patients aged 45 years or older and atypical lesions according to fine needle aspiration cytology (FNAC) or core needle biopsy (CNB) were associated with higher risk for postoperative malignant diagnosis with P values of 0.0008 and < 0.0001, respectively. Pathology review of 19 lesions with malignancy revealed that reasons for preoperative nonmalignant diagnosis were borderline lesions in nine (47.3%), sampling problem in six (31.5%), interpretation error in three (15.7%) and uninterpretable sample in one (5.2%).
CONCLUSIONS: In this cohort, 9.21% of preoperative nonmalignant papillary lesions were converted to malignant diagnosis after surgery. Atypical lesions and patients aged 45 years or older were significant factors associated with such conversion. Surgical excision should be considered for papillary lesions of breast, especially for patients with the identified risk factors.

Entities:  

Mesh:

Year:  2009        PMID: 19641969     DOI: 10.1245/s10434-009-0637-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

1.  Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision.

Authors:  Anupma Nayak; Selin Carkaci; Michael Z Gilcrease; Ping Liu; Lavinia P Middleton; Roland L Bassett; Jinxia Zhang; Hong Zhang; Robin L Coyne; Therese B Bevers; Nour Sneige; Lei Huo
Journal:  Clin Breast Cancer       Date:  2013-10-08       Impact factor: 3.225

2.  Intraductal Papilloma of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance.

Authors:  Jessica Limberg; Whitney Kucher; Genevieve Fasano; Syed Hoda; Aya Michaels; Jennifer L Marti
Journal:  Ann Surg Oncol       Date:  2021-04-19       Impact factor: 5.344

Review 3.  Non-malignant breast papillary lesions - b3 diagnosed on ultrasound--guided 14-gauge needle core biopsy: analysis of 114 cases from a single institution and review of the literature.

Authors:  Simonetta Bianchi; Benedetta Bendinelli; Valeria Saladino; Vania Vezzosi; Beniamino Brancato; Jacopo Nori; Domenico Palli
Journal:  Pathol Oncol Res       Date:  2015-01-10       Impact factor: 3.201

4.  Outcomes of benign intraductal papillomas diagnosed on core biopsy: a review of 104 cases with subsequent excision from a single institution.

Authors:  Jaya Ruth Asirvatham; Julie M Jorns; Lili Zhao; Deborah O Jeffries; Angela J Wu
Journal:  Virchows Arch       Date:  2018-09-06       Impact factor: 4.064

5.  Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesions.

Authors:  Miwa Yoshida; Hitoshi Tsuda; Sohei Yamamoto; Takayuki Kinoshita; Sadako Akashi-Tanaka; Takashi Hojo; Takashi Fukutomi
Journal:  Virchows Arch       Date:  2012-04-04       Impact factor: 4.064

6.  Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium.

Authors:  Tehillah S Menes; Robert Rosenberg; Steven Balch; Shabnam Jaffer; Karla Kerlikowske; Diana L Miglioretti
Journal:  Am J Surg       Date:  2013-10-07       Impact factor: 2.565

7.  Predictive Factors for Upgrading Patients with Benign Breast Papillary Lesions Using a Core Needle Biopsy.

Authors:  Young Ran Hong; Byung Joo Song; Sang Seol Jung; Bong Joo Kang; Sung Hun Kim; Byung Joo Chae
Journal:  J Breast Cancer       Date:  2016-12-23       Impact factor: 3.588

8.  Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience.

Authors:  Inha Jung; Min Jung Kim; Hee Jung Moon; Jung Hyun Yoon; Eun-Kyung Kim
Journal:  Ultrasonography       Date:  2017-05-17

9.  A retrospective observational study of intraductal breast papilloma and its coexisting lesions: A real-world experience.

Authors:  Xiaona Li; Huan Wang; Zhe Sun; Chuifeng Fan; Feng Jin; Xiaoyun Mao
Journal:  Cancer Med       Date:  2020-08-21       Impact factor: 4.452

10.  Results of Excision of Unknown Papillary Neoplasms Detected on Core Biopsy.

Authors:  Ayşe Nur Uğur Kılınç; Zeynep Bayramoğlu; Yaşar Ünlü; Nahide Baran; Ayşegül Altunkeser; Nergis Aksoy; Mehmet Ali Eryılmaz; Elif Nur Öztürk Yıldırım
Journal:  Eur J Breast Health       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.